{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:30:23Z","timestamp":1792193423298,"version":"4.4.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/wco.0b013e32833de6ab","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T06:22:59Z","timestamp":1280902979000},"page":"509-513","source":"Crossref","is-referenced-by-count":126,"title":["Neurological manifestations of primary Sjogren's syndrome"],"prefix":"10.1097","volume":"23","author":[{"given":"Josiah","family":"Chai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L","family":"Logigian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210206","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R2-11-20210206","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","article-title":"Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients","volume":"83","author":"Delalande","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"R4-11-20210206","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","article-title":"Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients","volume":"87","author":"Ramos-Casals","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"R5-11-20210206","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/archneur.63.11.1612","article-title":"Peripheral neuropathy in primary Sjogren syndrome: a population-based study","volume":"63","author":"Goransson","year":"2006","journal-title":"Arch Neurol"},{"key":"R6-11-20210206","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/brain\/awh605","article-title":"The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy","volume":"128","author":"Mori","year":"2005","journal-title":"Brain"},{"key":"R7-11-20210206","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/ard.49.10.775","article-title":"Pure sensory neuropathy in patients with primary Sjogren's syndrome: clinical, immunological, and electromyographic findings","volume":"49","author":"Font","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"R8-11-20210206","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1212\/WNL.48.4.855","article-title":"Peripheral neuropathy associated with sicca complex","volume":"48","author":"Grant","year":"1997","journal-title":"Neurology"},{"key":"R9-11-20210206","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s004150050106","article-title":"Early asymmetric neuropathy in primary Sjogren's syndrome","volume":"244","author":"Denislic","year":"1997","journal-title":"J Neurol"},{"key":"R10-11-20210206","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mus.20514","article-title":"Peripheral neuropathy in an outpatient cohort of patients with Sjogren's syndrome","volume":"33","author":"Lopate","year":"2006","journal-title":"Muscle Nerve"},{"key":"R11-11-20210206","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/mus.10470","article-title":"Positive salivary gland biopsy, Sjogren syndrome, and neuropathy: clinical implications","volume":"28","author":"Gorson","year":"2003","journal-title":"Muscle Nerve"},{"key":"R12-11-20210206","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.wnl.0000176034.38198.f9","article-title":"Painful small-fiber neuropathy in Sjogren syndrome","volume":"65","author":"Chai","year":"2005","journal-title":"Neurology"},{"key":"R13-11-20210206","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.410270313","article-title":"Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjogren's syndrome","volume":"27","author":"Griffin","year":"1990","journal-title":"Ann Neurol"},{"key":"R14-11-20210206","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.410200416","article-title":"Subacute sensory neuronopathy secondary to dorsal root ganglionitis in primary Sjogren's syndrome","volume":"20","author":"Malinow","year":"1986","journal-title":"Ann Neurol"},{"key":"R15-11-20210206","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1212\/WNL.39.3.390","article-title":"Peripheral neuropathy in primary Sjogren's syndrome","volume":"39","author":"Mellgren","year":"1989","journal-title":"Neurology"},{"key":"R16-11-20210206","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/rheumatology\/29.1.21","article-title":"The spectrum of neurological involvement in Sjogren's syndrome","volume":"29","author":"Andonopoulos","year":"1990","journal-title":"Br J Rheumatol"},{"key":"R17-11-20210206","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2169\/internalmedicine.41.142","article-title":"Motor dominant neuropathy in Sjogren's syndrome: report of two cases","volume":"41","author":"Mochizuki","year":"2002","journal-title":"Intern Med"},{"key":"R18-11-20210206","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/mus.21274","article-title":"Subacute inflammatory polyradiculopathy associated with Sjogren's syndrome","volume":"39","author":"Rigamonti","year":"2009","journal-title":"Muscle Nerve"},{"key":"R19-11-20210206","first-page":"74","article-title":"Comprehensive study of autonomic function in a population with primary Sjogren's syndrome. No evidence of autonomic involvement","volume":"30","author":"Niemela","year":"2003","journal-title":"J Rheumatol"},{"key":"R20-11-20210206","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0165-1838(98)00164-7","article-title":"Autonomic neuropathy associated with sicca complex","volume":"75","author":"Wright","year":"1999","journal-title":"J Auton Nerv Syst"},{"key":"R21-11-20210206","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0300-2977(98)00080-1","article-title":"Primary Sjogrens syndrome presenting as autonomic neuropathy. Case report.","volume":"53","author":"Barendregt","year":"1998","journal-title":"Neth J Med"},{"key":"R22-11-20210206","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1468-1331.2004.00846.x","article-title":"Primary Sjogren's syndrome presenting with generalized autonomic failure","volume":"11","author":"Sakakibara","year":"2004","journal-title":"Eur J Neurol"},{"key":"R23-11-20210206","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/rheumatology\/keg468","article-title":"Cardiovascular autonomic dysfunction in primary Sjogren's syndrome","volume":"43","author":"Kovacs","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"R24-11-20210206","first-page":"2385","article-title":"Autonomic cardiovascular neuropathy in Sjogren's syndrome. A controlled study","volume":"25","author":"Andonopoulos","year":"1998","journal-title":"J Rheumatol"},{"key":"R25-11-20210206","first-page":"717","article-title":"Subclinical myositis is common in primary Sj\u00f6gren's syndrome and is not related to muscle pain","volume":"29","author":"Lindvall","year":"2002","journal-title":"J Rheumatol"},{"key":"R26-11-20210206","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0404.1990.tb01601.x","article-title":"Neuropathy and myopathy in primary Sjogren's syndrome: neurophysiological, immunological and muscle biopsy results","volume":"82","author":"Vrethem","year":"1990","journal-title":"Acta Neurol Scand"},{"key":"R27-11-20210206","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1093\/brain\/awh662","article-title":"The clinical heterogeneity of immune sensory and autonomic neuropathies with (or without) sicca","volume":"128","author":"Dyck","year":"2005","journal-title":"Brain"},{"key":"R28-11-20210206","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00001756-200505120-00005","article-title":"Antiganglion neuron antibodies correlate with neuropathy in Sjogren's syndrome","volume":"16","author":"Murata","year":"2005","journal-title":"Neuroreport"},{"key":"R29-11-20210206","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/1529-0131(200007)43:7<1647::AID-ANR31>3.0.CO;2-P","article-title":"Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome","volume":"43","author":"Waterman","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R30-11-20210206","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.humimm.2005.01.020","article-title":"Neutralization of muscarinic receptor autoantibodies by intravenous immunoglobulin in Sjogren syndrome","volume":"66","author":"Smith","year":"2005","journal-title":"Hum Immunol"},{"key":"R31-11-20210206","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2169\/internalmedicine1962.30.452","article-title":"Peripheral neuropathy associated with Sjogren's syndrome: pathologic and immunologic study of two patients","volume":"30","author":"Inoue","year":"1991","journal-title":"Jpn J Med"},{"key":"R32-11-20210206","first-page":"617","article-title":"Spontaneous improvement of subacute exacerbation in a case of sensory ataxic neuropathy associated with Sjogren's syndrome","volume":"41","author":"Maruyama","year":"2001","journal-title":"Rinsho Shinkeigaku"},{"key":"R33-11-20210206","first-page":"539","article-title":"Two distinct types of neuropathy associated with Sjogren's syndrome developed in one patient. The importance of the selection of an appropriate therapeutic regimen","volume":"43","author":"Noguchi","year":"2003","journal-title":"Rinsho Shinkeigaku"},{"key":"R34-11-20210206","first-page":"1552","article-title":"Pure sensory neuropathy in primary Sjogren's syndrome. Longterm prospective followup and review of the literature","volume":"30","author":"Font","year":"2003","journal-title":"J Rheumatol"},{"key":"R35-11-20210206","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/jnnp.60.6.699","article-title":"Intravenous immunoglobulin therapy in sensory neuropathy associated with Sjogren's syndrome","volume":"60","author":"Molina","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R36-11-20210206","first-page":"421","article-title":"High-dose intravenous immunoglobulin in the treatment of sensory ataxic neuropathy with Sjogren's syndrome: a case report","volume":"56","author":"Taguchi","year":"2004","journal-title":"No To Shinkei"},{"key":"R37-11-20210206","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1212\/01.WNL.0000046680.47883.7D","article-title":"Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjogren's syndrome. IV immunoglobulin","volume":"60","author":"Takahashi","year":"2003","journal-title":"Neurology"},{"key":"R39-11-20210206","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/jnnp.2005.084533","article-title":"Intravenous immunoglobulin treatment in painful sensory neuropathy without sensory ataxia associated with Sjogren's syndrome","volume":"77","author":"Kizawa","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R40-11-20210206","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/s10165-009-0180-2","article-title":"Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjogren's syndrome","volume":"19","author":"Wakasugi","year":"2009","journal-title":"Mod Rheumatol"},{"key":"R41-11-20210206","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2008.12.018","article-title":"Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjogren's syndrome","volume":"279","author":"Morozumi","year":"2009","journal-title":"J Neurol Sci"},{"key":"R42-11-20210206","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000052142","article-title":"Plasmapheresis in the treatment of ataxic sensory neuropathy associated with Sjogren's syndrome","volume":"45","author":"Chen","year":"2001","journal-title":"Eur Neurol"},{"key":"R43-11-20210206","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1212\/WNL.51.5.1451","article-title":"D-penicillamine treatment for chronic sensory ataxic neuropathy associated with Sjogren's syndrome","volume":"51","author":"Asahina","year":"1998","journal-title":"Neurology"},{"key":"R44-11-20210206","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.59.7.1113","article-title":"Severe sensory neuronopathy responsive to infliximab in primary Sjogren's syndrome","volume":"59","author":"Caroyer","year":"2002","journal-title":"Neurology"},{"key":"R45-11-20210206","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.clineuro.2004.10.001","article-title":"Pulse-cyclophosphamide in the treatment of ataxic sensory and cranial nerve neuropathy associated with Sjogren's syndrome","volume":"107","author":"Kastrup","year":"2005","journal-title":"Clin Neurol Neurosurg"},{"key":"R46-11-20210206","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/mus.20664","article-title":"Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial","volume":"35","author":"Gorson","year":"2007","journal-title":"Muscle Nerve"},{"key":"R47-11-20210206","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00296-007-0396-4","article-title":"Successful treatment with rituximab in a patient with mental nerve neuropathy in primary Sjogren's syndrome","volume":"28","author":"Seve","year":"2007","journal-title":"Rheumatol Int"},{"key":"R48-11-20210206","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/CND.0b013e3181c50513","article-title":"Prolonged remission of a demyelinating neuropathy in a patient with lymphoma and Sjogren's syndrome after rituximab therapy","volume":"11","author":"Botez","year":"2010","journal-title":"J Clin Neuromuscul Dis"},{"key":"R49-11-20210206","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/jnnp.2004.049502","article-title":"Interferon alfa treatment for Sjogren's syndrome associated neuropathy","volume":"76","author":"Yamada","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Current Opinion in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WCO.0b013e32833de6ab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:10:17Z","timestamp":1620965417000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00019052-201010000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/wco.0b013e32833de6ab","relation":{},"ISSN":["1350-7540"],"issn-type":[{"value":"1350-7540","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}